ArticleGlobal health action2020
Reconciling model predictions with low reported cases of COVID-19 in Sub-Saharan Africa: insights from Madagascar.
Article in Global health action, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Article
- SARS-CoV-2 transmission dynamics in Mozambique and Zimbabwe during the first 3 years of the pandemic.Royal Society open science · 2025Article
- Toward resilience for public health emergency response system during COVID-19: qualitative comparative analyses of 40 countries.Frontiers in public health · 2025Article
- Article
- Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context.Nature communications · 2023Article
- The impact of age structure and vaccine prioritization on COVID-19 in West Africa.Infectious Disease Modelling · 2022Article
- Coordination mechanisms for COVID-19 in the WHO Regional office for Africa.BMC health services research · 2022Review
- Prioritizing COVID-19 vaccination efforts and dose allocation within Madagascar.BMC public health · 2022Article
- Cross-sectional cycle threshold values reflect epidemic dynamics of COVID-19 in Madagascar.Epidemics · 2022Article
- Existing human mobility data sources poorly predicted the spatial spread of SARS-CoV-2 in Madagascar.Epidemics · 2022Article
- Existing human mobility data sources poorly predicted the spatial spread of SARS-CoV-2 in Madagascar.medRxiv : the preprint server for health sciences · 2021Article
- Article
- Public mobility data enables COVID-19 forecasting and management at local and global scales.Scientific reports · 2021Article
- Variation in predicted COVID-19 risk among lemurs and lorises.American journal of primatology · 2021Article
- Non-pharmaceutical interventions during the COVID-19 pandemic: A review.Physics reports · 2021Review
- The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.Lancet (London, England) · 2021Observational
- Variation in predicted COVID-19 risk among lemurs and lorises.bioRxiv : the preprint server for biology · 2021Article
- The Determinants of the Low COVID-19 Transmission and Mortality Rates in Africa: A Cross-Country Analysis.Frontiers in public health · 2021Article
- Integrating Health Systems and Science to Respond to COVID-19 in a Model District of Rural Madagascar.Frontiers in public health · 2021Article
- What Can COVID-19 Teach Us about Using AI in Pandemics?Healthcare (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 has wreaked havoc globally with particular concerns for sub-Saharan Africa (SSA), where models suggest that the majority of the population will become infected. Conventional wisdom suggests that the continent will bear a higher burden of COVID-19 for the same reasons it suffers from other infectious diseases: ecology, socio-economic conditions, lack of water and sanitation infrastructure, and weak health systems. However, so far SSA has reported lower incidence and fatalities compared to the predictions of standard models and the experience of other regions of the world. There are three leading explanations, each with different implications for the final epidemic burden: (1) low case detection, (2) differences in epidemiology (e.g. low
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.